FDA Panel’s Approval Of Epilepsy Drug Paves Way For U.S.’s First Cannabis-Derived Prescription Medicine

An FDA advisory panel gave the green light to the drug, which treats epilepsy, and the full agency is expected to give its approval, as well, sometime in June.

from Kaiser Health News https://ift.tt/2J9Le4G